Nasal Spray For Migraines Gets FDA Approval
Drug Topics
MARCH 13, 2023
The spray, called Zavzpret, intends to help individuals who struggle with migraines but can't take oral medication because of nausea or vomiting
Mon.Mar 13, 2023
247 
Babson aims to shed Theranos curse with new blood testing tech
PharmaVoice
MARCH 13, 2023
Babson Diagnostics is trying to create a less invasive blood testing technology — can it gain trust in the post-Theranos era?
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
STAT
MARCH 13, 2023
An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered left shoulder and an allergy to pain medicine. In 16.6 days, it estimated, she would be ready to leave her nursing home. On the 17th day, her Medicare Advantage insurer, Security Health Plan, followed the algorithm and cut off payment for her care, concluding she was ready to return to the apartment where she lived alone.
Across therapy areas, GoodRx’s POS rebates improve access and affordability for cash-paying patients
PharmaVoice
MARCH 13, 2023
Across therapy areas, GoodRx Assist is a proven point-of-sale rebate program for cash-paying patients.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
With $43B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs'
Fierce Pharma
MARCH 13, 2023
With $43B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs' kdunleavy Mon, 03/13/2023 - 10:16
BIC joins forces with Eric Andre, Annie Murphy on EasyRinse razor launch
Drug Store News
MARCH 13, 2023
The brand is debuting the EasyRinse razor with its “All Shave. No Clog,” campaign starring comedian Eric Andre and actress Annie Murphy.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Veterans Health Administration will cover the newest Alzheimer’s drug
STAT
MARCH 13, 2023
In an unexpected move, the Veterans Health Administration decided that it will widely cover a new Alzheimer’s treatment , even as Medicare has decided to wait for additional data about the medicine before taking the same step. The VA will provide coverage to veterans who meet agency criteria for using the medicine — called Leqembi — as well as stipulations on the product labeling, according to a statement from Eisai, which is partnering with Biogen to market the treatment.
ECRI: The growing pediatric mental health crisis is 2023's biggest patient safety challenge
Fierce Healthcare
MARCH 13, 2023
ECRI: The growing pediatric mental health crisis is 2023's biggest patient safety challenge pminemyer Mon, 03/13/2023 - 16:55
Opinion: The second age of psychedelic therapies for mental health
STAT
MARCH 13, 2023
Psychedelics like psilocybin and ketamine are being touted as the next generation of treatment for depression, anxiety, and other mental health issues. There’s no question that a next generation is needed. But it’s not like flipping a switch: These therapies involve a novel administration paradigm, acceptance by regulatory bodies, and public appreciation of their unique medicinal value.
9 ways to improve your gut health
The Checkup by Singlecare
MARCH 13, 2023
If you think your stomach’s only job is to digest food, think again: The human gut plays a major role in your immune system and mental health. Meaning, when your gut is unhappy, there’s a good chance the rest of your body will be, too. An unhealthy gut, or dysbiosis, can cause inflammation in the gut, says physician and registered dietitian Amy Burkhart, MD, of The Celiac MD.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Pfizer buys Seagen, maker of targeted cancer drugs, for $43 billion
STAT
MARCH 13, 2023
Pfizer said Monday it is acquiring Seagen, a maker of targeted cancer drugs, for $43 billion. The deal helps Pfizer, flush with cash but in need of new sources of revenue due to declining sales of Covid treatments, by adding a lineup of cancer drugs called antibody-drug conjugates that work by delivering chemotherapy directly to tumors.
H-E-B offering digital access to home services
Drug Store News
MARCH 13, 2023
The regional grocery retailer is rolling out branded displays from Thumbtack, which provides homeowners digital access to home service providers, in more than 300 of its Texas-based stores.
STAT+: Buyer’s remorse: How a Medicare Advantage business is strangling one of its first funders
STAT
MARCH 13, 2023
When NaviHealth began building a business around using algorithms to scrutinize the care of older patients a decade ago, one of the country’s largest chains of inpatient rehab and long-term care hospitals was among the first to invest. Select Medical cut a check of about $5 million — a rounding error for a conglomerate that generates more than $6 billion of revenue every year.
Gut microbiome linked to cancer CAR T therapy response
European Pharmaceutical Review
MARCH 13, 2023
The largest prospective study of its kind has shown that obtaining individualised gut microbiome data prior to CAR T therapy could accurately predict treatment responsiveness. This was shown to only be possible if patients were not pre-treated with broad spectrum antibiotics. Immunotherapy with CD19 chimeric antigen receptor (CAR)-T cell has facilitated effective treatment options for patients with certain forms of refractory and relapsing B-cell leukaemia’s or lymphomas.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Illumina has been ignoring its investors, but it can’t ignore Carl Icahn
STAT
MARCH 13, 2023
Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he’s taken a stake in Illumina and wants three handpicked directors added to the company’s board. The message Illumina’s management should hear is this: Icahn usually gets much of what he wants.
Common Painpoints to Avoid When Shopping for Pharmacy Software
Digital Pharmacist
MARCH 13, 2023
Purchasing software can seem like a daunting task for pharmacy owners to tackle on top of all their other day-to-day tasks – but purchasing the right software can automate those tasks and thus free up so much valuable time in the long run. Today we will discuss some pain points to avoid in the process to help you choose wisely the first time and get to the end goal… a more efficient team and happier patients.
STAT+: Pharmalittle: Biogen exec who quarterbacked Aduhelm leaves; Pfizer to buy Seagen for $43 billion
STAT
MARCH 13, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings and deadlines has returned. But you knew this would happen, yes? After all, the world continues to spin no matter how we try to slow it down. So to cope, we are firing up the coffee kettle and brewing cups of stimulation.
SXSW 2023: Tech innovation in the spotlight, but SVB fallout casts a shadow
Fierce Healthcare
MARCH 13, 2023
SXSW 2023: Tech innovation in the spotlight, but SVB fallout casts a shadow hlandi Mon, 03/13/2023 - 07:34
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: French pharma Sanofi buys maker of diabetes treatment for $2.9 billion
STAT
MARCH 13, 2023
Sanofi said Monday that it is acquiring Provention Bio, makers of a diabetes treatment, for $2.9 billion. The Provention drug at the centerpiece of the deal, called TZield, was approved in the U.S. last November as the first and only treatment to prevent the onset of symptomatic Type 1 diabetes. Sanofi was already co-marketing the drug under a prior licensing deal signed between the two companies.
Giant recognizes team members during annual business meeting
Drug Store News
MARCH 13, 2023
The company granted 15 awards recognizing the recipients’ commitments to the company and their efforts to connect families for a better future.
STAT+: 102 hours of chaos: How SVB’s collapse rattled the biotech industry
STAT
MARCH 13, 2023
Paul Rennert was surprisingly energized after deplaning a transatlantic flight in Boston Thursday evening. He had just wrapped up weeks of international travel and investor meetings, and was pleased that even though the biotech industry was in the midst of one of the worst financing environments in years, venture capitalists had seemed receptive to the idea of investing in his startup, Aleta Biotherapeutics.
Injectable peptide rapidly reduces intracranial pressure
European Pharmaceutical Review
MARCH 13, 2023
Patients with Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a Phase II trial has found. According to the study results, brain pressure was significantly reduced within two and half hours after an injection of exenatide, a GLP-1 receptor agonist. IIH is a condition that raises pressure in the brain, likely due to a cerebrospinal fluid (CSF) imbalance.
Kroger hires former House Speaker Boehner to push for approval of proposed merger with Albertsons
Drug Store News
MARCH 13, 2023
Boehner, who is employed by Squire Patton Boggs, a law and lobbying company, will “provide strategic counsel” to Kroger executives and won’t register to lobby, according to a report in The Hill.
Patients seek appeal in landmark UnitedHealth mental health parity case
Fierce Healthcare
MARCH 13, 2023
Patients seek appeal in landmark UnitedHealth mental health parity case pminemyer Mon, 03/13/2023 - 15:36
So Delicious Dairy Free rolls out no added sugar yogurt alternative
Drug Store News
MARCH 13, 2023
The new yogurt alternative is available in four flavors—coconut, strawberry, vanilla and blueberry.
Sandoz to build biologics plant in Slovenia
European Pharmaceutical Review
MARCH 13, 2023
Sandoz has signed a Memorandum of Understanding (MOU) to build a new biologics production plant in Lendava, Slovenia. The company’s expected $400 million investment is the largest-ever international private-sector investment in the country. The “state-of-the-art” site will enable Sandoz “to meet growing demand for our current and future biosimilars in the mid- to long-term,” noted Glenn Gerecke, Global Head of Sandoz Technical Operations. “Not only does the location has offer c
Queen V survey explores women’s feelings about their vagina
Drug Store News
MARCH 13, 2023
Queen V’s data reveals that over half of women (52%) said their first intimate health issue had a negative impact on their emotional health and well-being and 41% said it made them not want to leave the house.
Oak Street Health: Medicare Advantage advance notice could divert resources from dual eligibles
Fierce Healthcare
MARCH 13, 2023
Oak Street Health: Medicare Advantage advance notice could divert resources from dual eligibles rking Mon, 03/13/2023 - 17:07
Sephora, TikTok pioneer Incubator Program for brands, content creators
Drug Store News
MARCH 13, 2023
The Sephora x TikTok Incubator Program aims to aid participants in learning impactful social content strategies through educational training modules, the companies said.
15% of adults have past-due medical debt. Much of that is owed to hospitals
Fierce Healthcare
MARCH 13, 2023
15% of adults have past-due medical debt.
Acadia's Daybue wins FDA nod as first treatment for Rett syndrome
Fierce Pharma
MARCH 13, 2023
Acadia's Daybue wins FDA nod as first treatment for Rett syndrome esagonowsky Mon, 03/13/2023 - 09:28
Advancing ‘Smart Pharma’ Capabilities in 2023 and Beyond
Pharmaceutical Commerce
MARCH 13, 2023
Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
MARCH 13, 2023
Sanofi throws down $2.
Let's personalize your content